BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 20726328)

  • 1. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
    Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
    Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.
    Valencia X; Yarboro C; Illei G; Lipsky PE
    J Immunol; 2007 Feb; 178(4):2579-88. PubMed ID: 17277168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.
    Hu S; Xiao W; Kong F; Ke D; Qin R; Su M
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):549-52. PubMed ID: 18846336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of CD4
    Kamal M; Gabr H; Anwar S; Bastawy S; Salah L
    Lupus; 2022 Apr; 31(4):463-471. PubMed ID: 35249399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang F; Zhu L; Liu Y
    Clin Exp Immunol; 2008 Aug; 153(2):182-7. PubMed ID: 18505426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus.
    Barath S; Aleksza M; Tarr T; Sipka S; Szegedi G; Kiss E
    Lupus; 2007; 16(7):489-96. PubMed ID: 17670847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients.
    Żabińska M; Krajewska M; Kościelska-Kasprzak K; Jakuszko K; Bartoszek D; Myszka M; Klinger M
    Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):399-407. PubMed ID: 27156107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
    Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
    Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+)FoxP3(+) regulatory T-cells in human systemic lupus erythematosus.
    Suen JL; Chiang BL
    J Formos Med Assoc; 2012 Sep; 111(9):465-70. PubMed ID: 23021502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.